Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
50.26
-0.86 (-1.68%)
At close: Feb 21, 2025, 4:00 PM
51.00
+0.74 (1.47%)
After-hours: Feb 21, 2025, 5:44 PM EST
Cytokinetics Employees
Cytokinetics had 423 employees as of December 31, 2023. The number of employees increased by 14 or 3.42% compared to the previous year.
Employees
423
Change (1Y)
14
Growth (1Y)
3.42%
Revenue / Employee
$7,610
Profits / Employee
-$1,362,652
Market Cap
5.93B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 423 | 14 | 3.42% |
Dec 31, 2022 | 409 | 156 | 61.66% |
Dec 31, 2021 | 253 | 69 | 37.50% |
Dec 31, 2020 | 184 | 28 | 17.95% |
Dec 31, 2019 | 156 | 26 | 20.00% |
Dec 31, 2018 | 130 | -7 | -5.11% |
Dec 31, 2017 | 137 | 10 | 7.87% |
Dec 31, 2016 | 127 | 27 | 27.00% |
Dec 31, 2015 | 100 | 8 | 8.70% |
Dec 31, 2014 | 92 | 7 | 8.24% |
Dec 31, 2013 | 85 | 15 | 21.43% |
Dec 31, 2012 | 70 | -9 | -11.39% |
Dec 31, 2011 | 79 | -26 | -24.76% |
Dec 31, 2010 | 105 | -6 | -5.41% |
Dec 31, 2009 | 111 | 1 | 0.91% |
Dec 31, 2008 | 110 | -51 | -31.68% |
Dec 31, 2007 | 161 | 13 | 8.78% |
Dec 31, 2006 | 148 | -2 | -1.33% |
Dec 31, 2005 | 150 | -20 | -11.76% |
Dec 31, 2004 | 170 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CYTK News
- 2 days ago - Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 days ago - 20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset' - Market Watch
- 8 days ago - Cytokinetics to Announce Fourth Quarter Results on February 27, 2025 - GlobeNewsWire
- 11 days ago - Cytokinetics Names Robert E. Landry to Board of Directors - GlobeNewsWire
- 16 days ago - Cytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 22 days ago - Kuehn Law Encourages Investors of Cytokinetics, Inc. to Contact Law Firm - PRNewsWire
- 23 days ago - Cytokinetics Announces Recipients of Its Seventh Annual Communications Grant Program - GlobeNewsWire
- 4 weeks ago - Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst - Benzinga